Key facts
- This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
- 13 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 21:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Footnote F2
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.00 to $205.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.52 to $207.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.55 to $208.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.2250 to $209.9200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
Footnote F7
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F8
Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Footnote F9
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F10
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.83 to $202.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F11
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.83 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F12
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F13
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F14
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.9750 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.